PTX-3 and zinc as potential markers of disease severity during sickle cell painful crisis

PTX-3 and zinc as potential markers of disease severity during sickle cell painful crisis - ZIP Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON37308

Enrollment

Registered

2012-09-25

Start date

2012-12-03

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sickle cell

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * High performance liquid chromatography confirmed diagnosis of HbSS, HbSC, HbS*0- or HbS*+-thalassemia genotype in SCD patients. * Written informed consent by the patient. *18 years and older

Exclusion criteria

Exclusion criteria: 1. Pregnancy 2. Active cancer 3. Chronic HIV infection 4. Recent vaso-occlusive crisis (

Countries

Netherlands

Outcome results